Here's how NATURE.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NATURE . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Nature.com Make Money
  6. How Much Does Nature.com Make
  7. Keywords
  8. Topics
  9. Schema
  10. Social Networks
  11. External Links
  12. Analytics And Tracking
  13. Libraries
  14. Hosting Providers
  15. CDN Services

We are analyzing https://www.nature.com/articles/s41467-018-05812-2.

Title:
SUMOylation of VEGFR2 regulates its intracellular trafficking and pathological angiogenesis | Nature Communications
Description:
Regulation of VEGFR2 represents an important mechanism for the control of angiogenesis. VEGFR2 activity can be regulated by post-translational modifications such as ubiquitination and acetylation. However, whether VEGFR2 can be regulated by SUMOylation has not been investigated. Here we show that endothelial-specific deletion of the SUMO endopeptidase SENP1 reduces pathological angiogenesis and tissue repair during hindlimb ischemia, and VEGF-induced angiogenesis in the cornea, retina, and ear. SENP1-deficient endothelial cells show increased SUMOylation of VEGFR2 and impaired VEGFR2 signalling. SUMOylation at lysine 1270 retains VEGFR2 in the Golgi and reduces its surface expression, attenuating VEGFR2-dependent signalling. Moreover, we find that SENP1 is downregulated and VEGFR2 hyper-SUMOylated in diabetic settings and that expression of a non-SUMOylated form of VEGFR2 rescues angiogenic defects in diabetic mice. These results show that VEGFR2 is regulated by deSUMOylation during pathological angiogenesis, and propose SENP1 as a potential therapeutic target for the treatment of diabetes-associated angiogenesis. VEGFR2 is a central regulator of angiogenesis. Here Zhou et al. report that SUMOylation of VEGFR2 regulates its subcellular localisation and activity, and that endothelial-specific knockout of the SUMO endopeptidase SENP1 protects against VEGFR2-mediated pathological angiogenesis.
Website Age:
30 years and 10 months (reg. 1994-08-11).

Matching Content Categories {πŸ“š}

  • Science
  • Education
  • Telecommunications

Content Management System {πŸ“}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of nature.com audience?

πŸŒ† Monumental Traffic: 20M - 50M visitors per month


Based on our best estimate, this website will receive around 42,555,829 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {πŸ’Έ}


Display Ads {🎯}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.com

Reseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.com

How Much Does Nature.com Make? {πŸ’°}


Display Ads {🎯}

$536,300 per month
Our calculations suggest that Nature.com earns between $357,511 and $983,155 monthly online from display advertisements.

Keywords {πŸ”}

vegfr, senp, angiogenesis, pubmed, mice, article, fig, google, scholar, cells, endothelial, sumoylation, cas, cell, senpecko, expression, protein, signalling, golgi, vascular, vegf, vegfinduced, central, angiogenic, vegfrsumo, sumo, pathological, supplementary, ear, nature, trafficking, surface, assay, data, deletion, growth, performed, images, shown, human, mouse, group, ecs, vegfrwt, min, retina, signaling, sumoylated, normal, study,

Topics {βœ’οΈ}

1 mm ez-link sulfo-nhs-lc-biotin nature portfolio crispr/cas9-mediated gene editing crispr-cas9-mediated gene editing ve-cadherin-cre-recombinase transgenic mouse privacy policy national key research performed research advertising open active state mediated gene editing nature 473 nature 465 nature reprints sumoylation-defective mutant vegfr2-k1270r vascular development vivo genome editing ve-cadherin-cre mice24 prepare single-stranded dna /liter polyoxyethylene-8-lauryl ether pe-conjugated anti-cd31 overnight exhibit reduced ischemia-induced prdx2/c-myc axis vegfr-2-mediated plcgamma1 activation enhance ask1-dependent apoptosis full size image trans-lentiviral packaging system vegf-induced ec migration vegf-a-dependent arteriogenesis adenovirus encoding vegf-a164 thermo fisher scientific development program real-time rt-pcr kdr-sumo1 knockin ec ve-cadherin-cre mice pi3k–akt–mtor pathway single-strand repair template vwr scientific international specific single-guide rna nrp1 mediates binding attenuating vegfr2-dependent signalling senp1-vegfr2 pathway plays vegfr2-sumo1 fusion compared myosin-vi binding motif pe-conjugated anti-cd31 senp1-vegfr2 angiogenic pathway ovarian cancer growth hif1Ξ±-dependent vegf transcription21 vegfr2-sumo1 fusion protein

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:SUMOylation of VEGFR2 regulates its intracellular trafficking and pathological angiogenesis
         description:Regulation of VEGFR2 represents an important mechanism for the control of angiogenesis. VEGFR2 activity can be regulated by post-translational modifications such as ubiquitination and acetylation. However, whether VEGFR2 can be regulated by SUMOylation has not been investigated. Here we show that endothelial-specific deletion of the SUMO endopeptidase SENP1 reduces pathological angiogenesis and tissue repair during hindlimb ischemia, and VEGF-induced angiogenesis in the cornea, retina, and ear. SENP1-deficient endothelial cells show increased SUMOylation of VEGFR2 and impaired VEGFR2 signalling. SUMOylation at lysine 1270 retains VEGFR2 in the Golgi and reduces its surface expression, attenuating VEGFR2-dependent signalling. Moreover, we find that SENP1 is downregulated and VEGFR2 hyper-SUMOylated in diabetic settings and that expression of a non-SUMOylated form of VEGFR2 rescues angiogenic defects in diabetic mice. These results show that VEGFR2 is regulated by deSUMOylation during pathological angiogenesis, and propose SENP1 as a potential therapeutic target for the treatment of diabetes-associated angiogenesis. VEGFR2 is a central regulator of angiogenesis. Here Zhou et al. report that SUMOylation of VEGFR2 regulates its subcellular localisation and activity, and that endothelial-specific knockout of the SUMO endopeptidase SENP1 protects against VEGFR2-mediated pathological angiogenesis.
         datePublished:2018-08-17T00:00:00Z
         dateModified:2019-08-15T00:00:00Z
         pageStart:1
         pageEnd:16
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1038/s41467-018-05812-2
         keywords:
            Angiogenesis
            Protein translocation
            Sumoylation
            Science
            Humanities and Social Sciences
            multidisciplinary
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-018-05812-2/MediaObjects/41467_2018_5812_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-018-05812-2/MediaObjects/41467_2018_5812_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-018-05812-2/MediaObjects/41467_2018_5812_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-018-05812-2/MediaObjects/41467_2018_5812_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-018-05812-2/MediaObjects/41467_2018_5812_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-018-05812-2/MediaObjects/41467_2018_5812_Fig6_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-018-05812-2/MediaObjects/41467_2018_5812_Fig7_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-018-05812-2/MediaObjects/41467_2018_5812_Fig8_HTML.png
         isPartOf:
            name:Nature Communications
            issn:
               2041-1723
            volumeNumber:9
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Huanjiao Jenny Zhou
               affiliation:
                     name:Yale University School of Medicine
                     address:
                        name:Interdepartmental Program in Vascular Biology and Therapeutics, Department of Pathology, Yale University School of Medicine, New Haven, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Zhe Xu
               affiliation:
                     name:Yale University School of Medicine
                     address:
                        name:Interdepartmental Program in Vascular Biology and Therapeutics, Department of Pathology, Yale University School of Medicine, New Haven, USA
                        type:PostalAddress
                     type:Organization
                     name:First Affiliated Hospital of Jinan University
                     address:
                        name:Department of Ophthalmology, First Affiliated Hospital of Jinan University, Guangzhou, P. R. China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Zongren Wang
               affiliation:
                     name:Yale University School of Medicine
                     address:
                        name:Interdepartmental Program in Vascular Biology and Therapeutics, Department of Pathology, Yale University School of Medicine, New Haven, USA
                        type:PostalAddress
                     type:Organization
                     name:Sun Yat-sen University
                     address:
                        name:The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, P. R. China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Haifeng Zhang
               affiliation:
                     name:Yale University School of Medicine
                     address:
                        name:Interdepartmental Program in Vascular Biology and Therapeutics, Department of Pathology, Yale University School of Medicine, New Haven, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Zhen W. Zhuang
               affiliation:
                     name:Yale University School of Medicine
                     address:
                        name:Section of Cardiology, Department of Internal Medicine, Yale University School of Medicine, New Haven, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Michael Simons
               url:http://orcid.org/0000-0003-0348-7734
               affiliation:
                     name:Yale University School of Medicine
                     address:
                        name:Section of Cardiology, Department of Internal Medicine, Yale University School of Medicine, New Haven, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Wang Min
               url:http://orcid.org/0000-0002-2479-6096
               affiliation:
                     name:Yale University School of Medicine
                     address:
                        name:Interdepartmental Program in Vascular Biology and Therapeutics, Department of Pathology, Yale University School of Medicine, New Haven, USA
                        type:PostalAddress
                     type:Organization
                     name:Sun Yat-sen University
                     address:
                        name:The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, P. R. China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:SUMOylation of VEGFR2 regulates its intracellular trafficking and pathological angiogenesis
      description:Regulation of VEGFR2 represents an important mechanism for the control of angiogenesis. VEGFR2 activity can be regulated by post-translational modifications such as ubiquitination and acetylation. However, whether VEGFR2 can be regulated by SUMOylation has not been investigated. Here we show that endothelial-specific deletion of the SUMO endopeptidase SENP1 reduces pathological angiogenesis and tissue repair during hindlimb ischemia, and VEGF-induced angiogenesis in the cornea, retina, and ear. SENP1-deficient endothelial cells show increased SUMOylation of VEGFR2 and impaired VEGFR2 signalling. SUMOylation at lysine 1270 retains VEGFR2 in the Golgi and reduces its surface expression, attenuating VEGFR2-dependent signalling. Moreover, we find that SENP1 is downregulated and VEGFR2 hyper-SUMOylated in diabetic settings and that expression of a non-SUMOylated form of VEGFR2 rescues angiogenic defects in diabetic mice. These results show that VEGFR2 is regulated by deSUMOylation during pathological angiogenesis, and propose SENP1 as a potential therapeutic target for the treatment of diabetes-associated angiogenesis. VEGFR2 is a central regulator of angiogenesis. Here Zhou et al. report that SUMOylation of VEGFR2 regulates its subcellular localisation and activity, and that endothelial-specific knockout of the SUMO endopeptidase SENP1 protects against VEGFR2-mediated pathological angiogenesis.
      datePublished:2018-08-17T00:00:00Z
      dateModified:2019-08-15T00:00:00Z
      pageStart:1
      pageEnd:16
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1038/s41467-018-05812-2
      keywords:
         Angiogenesis
         Protein translocation
         Sumoylation
         Science
         Humanities and Social Sciences
         multidisciplinary
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-018-05812-2/MediaObjects/41467_2018_5812_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-018-05812-2/MediaObjects/41467_2018_5812_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-018-05812-2/MediaObjects/41467_2018_5812_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-018-05812-2/MediaObjects/41467_2018_5812_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-018-05812-2/MediaObjects/41467_2018_5812_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-018-05812-2/MediaObjects/41467_2018_5812_Fig6_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-018-05812-2/MediaObjects/41467_2018_5812_Fig7_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-018-05812-2/MediaObjects/41467_2018_5812_Fig8_HTML.png
      isPartOf:
         name:Nature Communications
         issn:
            2041-1723
         volumeNumber:9
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Huanjiao Jenny Zhou
            affiliation:
                  name:Yale University School of Medicine
                  address:
                     name:Interdepartmental Program in Vascular Biology and Therapeutics, Department of Pathology, Yale University School of Medicine, New Haven, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Zhe Xu
            affiliation:
                  name:Yale University School of Medicine
                  address:
                     name:Interdepartmental Program in Vascular Biology and Therapeutics, Department of Pathology, Yale University School of Medicine, New Haven, USA
                     type:PostalAddress
                  type:Organization
                  name:First Affiliated Hospital of Jinan University
                  address:
                     name:Department of Ophthalmology, First Affiliated Hospital of Jinan University, Guangzhou, P. R. China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Zongren Wang
            affiliation:
                  name:Yale University School of Medicine
                  address:
                     name:Interdepartmental Program in Vascular Biology and Therapeutics, Department of Pathology, Yale University School of Medicine, New Haven, USA
                     type:PostalAddress
                  type:Organization
                  name:Sun Yat-sen University
                  address:
                     name:The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, P. R. China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Haifeng Zhang
            affiliation:
                  name:Yale University School of Medicine
                  address:
                     name:Interdepartmental Program in Vascular Biology and Therapeutics, Department of Pathology, Yale University School of Medicine, New Haven, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Zhen W. Zhuang
            affiliation:
                  name:Yale University School of Medicine
                  address:
                     name:Section of Cardiology, Department of Internal Medicine, Yale University School of Medicine, New Haven, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Michael Simons
            url:http://orcid.org/0000-0003-0348-7734
            affiliation:
                  name:Yale University School of Medicine
                  address:
                     name:Section of Cardiology, Department of Internal Medicine, Yale University School of Medicine, New Haven, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Wang Min
            url:http://orcid.org/0000-0002-2479-6096
            affiliation:
                  name:Yale University School of Medicine
                  address:
                     name:Interdepartmental Program in Vascular Biology and Therapeutics, Department of Pathology, Yale University School of Medicine, New Haven, USA
                     type:PostalAddress
                  type:Organization
                  name:Sun Yat-sen University
                  address:
                     name:The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, P. R. China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Nature Communications
      issn:
         2041-1723
      volumeNumber:9
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Yale University School of Medicine
      address:
         name:Interdepartmental Program in Vascular Biology and Therapeutics, Department of Pathology, Yale University School of Medicine, New Haven, USA
         type:PostalAddress
      name:Yale University School of Medicine
      address:
         name:Interdepartmental Program in Vascular Biology and Therapeutics, Department of Pathology, Yale University School of Medicine, New Haven, USA
         type:PostalAddress
      name:First Affiliated Hospital of Jinan University
      address:
         name:Department of Ophthalmology, First Affiliated Hospital of Jinan University, Guangzhou, P. R. China
         type:PostalAddress
      name:Yale University School of Medicine
      address:
         name:Interdepartmental Program in Vascular Biology and Therapeutics, Department of Pathology, Yale University School of Medicine, New Haven, USA
         type:PostalAddress
      name:Sun Yat-sen University
      address:
         name:The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, P. R. China
         type:PostalAddress
      name:Yale University School of Medicine
      address:
         name:Interdepartmental Program in Vascular Biology and Therapeutics, Department of Pathology, Yale University School of Medicine, New Haven, USA
         type:PostalAddress
      name:Yale University School of Medicine
      address:
         name:Section of Cardiology, Department of Internal Medicine, Yale University School of Medicine, New Haven, USA
         type:PostalAddress
      name:Yale University School of Medicine
      address:
         name:Section of Cardiology, Department of Internal Medicine, Yale University School of Medicine, New Haven, USA
         type:PostalAddress
      name:Yale University School of Medicine
      address:
         name:Interdepartmental Program in Vascular Biology and Therapeutics, Department of Pathology, Yale University School of Medicine, New Haven, USA
         type:PostalAddress
      name:Sun Yat-sen University
      address:
         name:The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, P. R. China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Huanjiao Jenny Zhou
      affiliation:
            name:Yale University School of Medicine
            address:
               name:Interdepartmental Program in Vascular Biology and Therapeutics, Department of Pathology, Yale University School of Medicine, New Haven, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Zhe Xu
      affiliation:
            name:Yale University School of Medicine
            address:
               name:Interdepartmental Program in Vascular Biology and Therapeutics, Department of Pathology, Yale University School of Medicine, New Haven, USA
               type:PostalAddress
            type:Organization
            name:First Affiliated Hospital of Jinan University
            address:
               name:Department of Ophthalmology, First Affiliated Hospital of Jinan University, Guangzhou, P. R. China
               type:PostalAddress
            type:Organization
      name:Zongren Wang
      affiliation:
            name:Yale University School of Medicine
            address:
               name:Interdepartmental Program in Vascular Biology and Therapeutics, Department of Pathology, Yale University School of Medicine, New Haven, USA
               type:PostalAddress
            type:Organization
            name:Sun Yat-sen University
            address:
               name:The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, P. R. China
               type:PostalAddress
            type:Organization
      name:Haifeng Zhang
      affiliation:
            name:Yale University School of Medicine
            address:
               name:Interdepartmental Program in Vascular Biology and Therapeutics, Department of Pathology, Yale University School of Medicine, New Haven, USA
               type:PostalAddress
            type:Organization
      name:Zhen W. Zhuang
      affiliation:
            name:Yale University School of Medicine
            address:
               name:Section of Cardiology, Department of Internal Medicine, Yale University School of Medicine, New Haven, USA
               type:PostalAddress
            type:Organization
      name:Michael Simons
      url:http://orcid.org/0000-0003-0348-7734
      affiliation:
            name:Yale University School of Medicine
            address:
               name:Section of Cardiology, Department of Internal Medicine, Yale University School of Medicine, New Haven, USA
               type:PostalAddress
            type:Organization
      name:Wang Min
      url:http://orcid.org/0000-0002-2479-6096
      affiliation:
            name:Yale University School of Medicine
            address:
               name:Interdepartmental Program in Vascular Biology and Therapeutics, Department of Pathology, Yale University School of Medicine, New Haven, USA
               type:PostalAddress
            type:Organization
            name:Sun Yat-sen University
            address:
               name:The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, P. R. China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Interdepartmental Program in Vascular Biology and Therapeutics, Department of Pathology, Yale University School of Medicine, New Haven, USA
      name:Interdepartmental Program in Vascular Biology and Therapeutics, Department of Pathology, Yale University School of Medicine, New Haven, USA
      name:Department of Ophthalmology, First Affiliated Hospital of Jinan University, Guangzhou, P. R. China
      name:Interdepartmental Program in Vascular Biology and Therapeutics, Department of Pathology, Yale University School of Medicine, New Haven, USA
      name:The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, P. R. China
      name:Interdepartmental Program in Vascular Biology and Therapeutics, Department of Pathology, Yale University School of Medicine, New Haven, USA
      name:Section of Cardiology, Department of Internal Medicine, Yale University School of Medicine, New Haven, USA
      name:Section of Cardiology, Department of Internal Medicine, Yale University School of Medicine, New Haven, USA
      name:Interdepartmental Program in Vascular Biology and Therapeutics, Department of Pathology, Yale University School of Medicine, New Haven, USA
      name:The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, P. R. China

External Links {πŸ”—}(224)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Prism.js
  • Zoom.js

Emails and Hosting {βœ‰οΈ}

Mail Servers:

  • mxa-002c5801.gslb.pphosted.com
  • mxb-002c5801.gslb.pphosted.com

Name Servers:

  • pdns1.ultradns.net
  • pdns2.ultradns.net
  • pdns3.ultradns.org
  • pdns4.ultradns.org
  • pdns5.ultradns.info
  • pdns6.ultradns.co.uk

CDN Services {πŸ“¦}

  • Crossref

5.92s.